DEC 12, 2017 10:00 AM PST

WEBINAR: Gold Standards and innovative processes for DC research in immuno-oncology

Sponsored by: Miltenyi Biotec
Speaker

Abstract

DATE: December 12, 2017
TIME: 10:00AM PT

Since their discovery, dendritic cells (DCs) have demonstrated a central role in the development of effective immune responses. Their unique ability to induce T cells responses to unknown antigens made them interesting research targets. However, DCs are not an easy cell type to study due to their low frequency in the periphery, lack of univocal lineage markers and the fact that they cannot be expanded in vitro. Artificial systems have been developed to obtain DC-like cells in numbers compatible with their study. The standard is to generate DCs from peripheral blood progenitors. This method has been instrumental in developing not only our basic understanding of these cells but also in translational aspects. Although the safety profile of DC approaches  has been proven in several trials and objective responses were observed, their study has been hindered by technical difficulties, especially in clinical settings. Recently, individual DCs subtypes have been shown to respond differently to specific pathogen and tumor environments and that they may functionally complement each other to evoke an effective immune response.
The recent progress in immuno-oncology and the rapid development of new drugs, give us potential to design novel and effective combination strategies to contrast the complex tumor settings. DCs may be an invaluable part of approaches aiming at targeting several checkpoints of anti-tumoral immune responses. To facilitate translational studies with DCs we developed state of the art automated and closed processes to obtain clinical scale DCs, reagents produced under good manufacturing practice (GMP) and analysis tools. In this webinar we will illustrate the CliniMACS Prodigy LP-14 System for generation of monocyte-derived DCs and the innovative LP-BDC for isolation and activation of primary DCs to investigate their clinical potential.

Learning Objectives:

  • Review recent progress in immuno-oncology
  • Review generation of monocyte-derived DCs 

 

The CliniMACS System components, including Reagents, Tubing Sets, Instruments, and PBS/EDTA Buffer, are manufactured and controlled under an ISO 13485-certified quality system. In the EU, the CliniMACS System components are available as CE-marked medical devices. In the US, the CliniMACS Prodigy LP-14 System is for research use only. CliniMACS MicroBeads are for research use only and not for human therapeutic or diagnostic use. Unless otherwise specifically indicated, Miltenyi Biotec products and services are for research only and not for therapeutic or diagnostic use. CliniMACS, CliniMACS Prodigy, and MACS® are registered trademarks of Miltenyi Biotec GmbH. Copyright© 2017 Miltenyi BiotecPRO. All rights reserved.


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
NOV 17, 2021 8:00 AM PST
C.E. CREDITS
NOV 17, 2021 8:00 AM PST
Date: November 17, 2021 Time: 8:00am (PDT), 11:00am (EDT) From waste disposal to promising biomarkers and therapeutic agents, exosomes and other extracellular vesicles are valuable in resear...
JUN 03, 2021 12:00 PM CST
JUN 03, 2021 12:00 PM CST
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...
DEC 12, 2017 10:00 AM PST

WEBINAR: Gold Standards and innovative processes for DC research in immuno-oncology

Sponsored by: Miltenyi Biotec

Specialty

Cancer Research

Immunology

Molecular Biology

Cancer Therapeutics

Biotechnology

Cancer Diagnostics

Cell Biology

Cell Culture

Clinical Diagnostics

Immuno-Oncology

Clinical Research

Molecular Diagnostics

Biomarkers

Genetics

Oncology

Geography

North America57%

Europe29%

Asia6%

South America4%

Oceania1%

Africa1%

Registration Source

Website Visitors100%

Job Title

Student13%

Facility/Department Manager12%

Executive11%

Scientist10%

Medical Laboratory Technician9%

Research Scientist9%

Educator/Faculty7%

Clinical Laboratory Scientist7%

Medical Doctor/Specialist5%

Post Doc5%

Lab Management5%

QC/QA3%

Marketing/Sales2%

Consultant1%

Biologist1%

Organization

Academic Institution13%

Biotech Company12%

Clinical Laboratory7%

Hospital7%

Research Institute4%

Pharmaceutical Company4%

Medical School4%

Life Science Company2%

Government2%

Medical Center2%

Consultant2%

Ambulatory Care2%

Non-Profit Organization1%

Industrial Company1%

Other4%


Show Resources
Loading Comments...
Show Resources